A Cost-Consequence Analysis of Pregabalin versus Usual Care in the Symptomatic Treatment of Refractory Low Back Pain: Sub-Analysis of Observational Trial Data from Orthopaedic Surgery and Rehabilitation Clinics

Author： Morera-Domínguez Carles  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.8, 2010-08, pp. : 517-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Cost-Consequence Analysis in Healthcare Decision-Making

By Mauskopf J.A.  

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 277-288

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Ziprasidone versus Haloperidol in Sequential Intramuscular/Oral Treatment of Exacerbation of Schizophrenia: Economic Subanalysis of the ZIMO Trial1 1 On behalf of the ZIMO trial collaborative group (see Acknowledgements).

By Cañas Fernando  

Clinical Drug Investigation, Vol. 27, Iss. 9, 2007-01 ,pp. : 633-645

Adis International

Access to resources Recommend Favorite

Pregabalin improves on usual care in neuropathic pain

By  

Inpharma, Vol. 1, Iss. 1519, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

A Multicentre, Randomised, Double-Blind Study Comparing the Efficacy and Tolerability of Intramuscular Dexketoprofen versus Diclofenac in the Symptomatic Treatment of Acute Low Back Pain

By Zippel H.   Wagenitz A.  

Clinical Drug Investigation, Vol. 27, Iss. 8, 2007-01 ,pp. : 533-543

Adis International

Access to resources Recommend Favorite

Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients: Observational Data from the Randomized POTENT Trial

By Elgadi Mabrouk M.  

Drugs in R&D, Vol. 11, Iss. 4, 2011-12 ,pp. : 295-302

Adis International

Access to resources Recommend Favorite